Biosimilars: Learn More

Learn how biosimilars are used in the practice of gastroenterology in the US from Comprehensive Update of Biosimilar Therapies: Your Questions Answered - a recorded version of a live webinar held on December 11, 2017. The webcast covers both current evidence on biosimilars for inflammatory bowel diseases and novel approaches to patient education on this topic. The presentations and panelists include:

• Introduction to Biosimilars - Dr. Gary R. Lichtenstein
• Panel Discussion - Dr. Brian G. Feagan, Dr. David T. Rubin, Kira (Patient)
• Q&A

System requirements

This program is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc.

This webcast is a collaboration of the AGA Institute and the Crohn's & Colitis Foundation.

For more information about the Crohn’s & Colitis Foundation, visit www.crohnscolitisfoundation.org.

For more information about the American Gastroenterological Association, visit www.gastro.org.